Glibenclamide-Induced Apoptosis Is Specifically Enhanced by Expression of the Sulfonylurea Receptor Isoform SUR1 but Not by Expression of SUR2B or the Mutant SUR1(M1289T)
Authors:
- Annette HambrockAHAnnette Hambrock
- Claudia Bernardo de Oliveira FranzCFClaudia Bernardo de Oliveira Franz
Open Access
- 1 March 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 316 (3) , 1031-1037
Abstract
Sulfonylurea receptor 1 (SUR1) is the regulatory subunit of the pancreatic ATP-sensitive K+ channel (KATP channel), which is essential for triggering insulin secretion via membrane depolarization. Sulfonylureas, such as glibenclamide and tolbutamide, act as KATP channel blockers and are widely used in diabetes treatment. These antidiabetic substances are known to induce apoptosis in pancreatic β-cells or β-cell lines under certain conditions. However, the precise molecular mechanisms of this sulfonylurea-induced apoptosis are still unidentified. To investigate the role of SUR in apoptosis induction, we tested the effect of glibenclamide on recombinant human embryonic kidney 293 cells expressing either SUR1, the smooth muscular isoform SUR2B, or the mutant SUR1(M1289T) at which a single amino acid in transmembrane helix 17 (TM17) was exchanged by the corresponding amino acid of SUR2. By analyzing cell detachment, nuclear condensation, DNA fragmentation, and caspase-3-like activity, we observed a SUR1-specific enhancement of glibenclamide-induced apoptosis that was not seen in SUR2B, SUR1(M1289T), or control cells. Coexpression with the pore-forming Kir6.2 subunit did not significantly alter the apoptotic effect of glibenclamide on SUR1 cells. In conclusion, expression of SUR1, but not of SUR2B or SUR1(M1289T), renders cells more susceptible to glibenclamide-induced apoptosis. Therefore, SUR1 as a pancreatic protein could be involved in specific variation of β-cell mass and might also contribute to the regulation of insulin secretion at this level. According to our results, TM17 is essentially involved in SUR1-mediated apoptosis. This effect does not require the presence of functional Kir6.2-containing KATP channels, which points to additional, so far unknown functions of SUR.Keywords
This publication has 41 references indexed in Scilit:
- Pas de deux in groups of four—the biogenesis of K channelsJournal of Molecular and Cellular Cardiology, 2005
- Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic CellsInfection and Immunity, 2005
- Insulin and dexamethasone inhibit TGF-β-induced apoptosis of hepatoma cells upstream of the caspase activation cascadeToxicology, 2004
- Both Triggering and Amplifying Pathways Contribute to Fuel-induced Insulin Secretion in the Absence of Sulfonylurea Receptor-1 in Pancreatic β-CellsJournal of Biological Chemistry, 2004
- AnoikisBiochemical Society Transactions, 2004
- Pharmacological Agents That Directly Modulate Insulin SecretionPharmacological Reviews, 2003
- Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotidesBritish Journal of Pharmacology, 2002
- The β-Cell K ATP ChannelThe Journal of Membrane Biology, 2000
- Sustained Enhancement of Ca2+ Influx by Glibenclamide Induces Apoptosis in RINm5F CellsBiochemical and Biophysical Research Communications, 2000
- Glibenclamide Induces Apoptosis through Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl− Channels and Intracellular Ca2+ Release in HepG2 Human Hepatoblastoma CellsBiochemical and Biophysical Research Communications, 1999